Total Payments
$13,910
2024 Payments
$2,294
Companies
52
Transactions
876
Medicare Patients
3,447
Medicare Billing
$307,739
Payment Breakdown by Category
Food & Beverage$13,796 (99.2%)
Education$114.65 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,796 | 872 | 99.2% |
| Education | $114.65 | 4 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,390 | 130 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,375 | 64 | $0 (2024) |
| PFIZER INC. | $1,230 | 93 | $0 (2024) |
| Novo Nordisk Inc | $1,160 | 84 | $0 (2024) |
| GlaxoSmithKline, LLC. | $869.38 | 45 | $0 (2024) |
| Amgen Inc. | $592.91 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $577.93 | 41 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $539.09 | 38 | $0 (2024) |
| Lilly USA, LLC | $506.70 | 35 | $0 (2024) |
| Allergan, Inc. | $487.01 | 64 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,294 | 116 | ABBVIE INC. ($402.67) |
| 2023 | $1,969 | 109 | ABBVIE INC. ($584.43) |
| 2022 | $1,547 | 85 | ABBVIE INC. ($531.00) |
| 2021 | $2,919 | 162 | AbbVie Inc. ($872.38) |
| 2020 | $1,838 | 131 | Novo Nordisk Inc ($257.30) |
| 2019 | $1,037 | 80 | PFIZER INC. ($179.24) |
| 2018 | $1,065 | 90 | PFIZER INC. ($203.05) |
| 2017 | $1,242 | 103 | PFIZER INC. ($284.65) |
All Payment Transactions
876 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: VACCINES | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $55.52 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Cardio-renal | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $71.84 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: VACCINES | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: VACCINE | ||||||
| 10/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Cardio-renal | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: PAIN | ||||||
| 09/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Gastroenterology | ||||||
| 09/20/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 817 | 1,595 | $247,263 | $85,719 |
| 2022 | 16 | 801 | 1,396 | $216,816 | $73,592 |
| 2021 | 19 | 932 | 1,690 | $234,217 | $82,858 |
| 2020 | 18 | 897 | 1,618 | $177,203 | $65,570 |
Total Patients
3,447
Total Services
6,299
Medicare Billing
$307,739
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 551 | $136,648 | $40,453 | 29.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $19,608 | $10,329 | 52.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 111 | $18,870 | $5,742 | 30.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $12,350 | $5,356 | 43.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 12 | 69 | $14,283 | $4,997 | 35.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 61 | 62 | $8,370 | $4,689 | 56.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 22 | 22 | $8,228 | $3,380 | 41.1% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 22 | 22 | $4,290 | $2,827 | 65.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 72 | 73 | $2,920 | $2,090 | 71.6% |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | Office | 2023 | 13 | 14 | $5,530 | $1,957 | 35.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 22 | 22 | $1,078 | $839.74 | 77.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 18 | $4,900 | $814.04 | 16.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 43 | 71 | $3,266 | $658.35 | 20.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $741.00 | $543.97 | 73.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 13 | 15 | $2,025 | $337.05 | 16.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 11 | 11 | $473.00 | $240.90 | 50.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 14 | 23 | $713.00 | $194.31 | 27.3% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 20 | 20 | $940.00 | $190.40 | 20.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 15 | 15 | $270.00 | $51.15 | 18.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 32 | 352 | $1,760 | $30.50 | 1.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 234 | 482 | $119,536 | $35,765 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 74 | 74 | $16,872 | $9,050 | 53.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 178 | $30,260 | $9,020 | 29.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 15 | 67 | $13,869 | $4,439 | 32.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 55 | 57 | $7,645 | $3,997 | 52.3% |
About Dr. David Page, M.D
Dr. David Page, M.D is a Family Medicine healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598768848.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Page, M.D has received a total of $13,910 in payments from pharmaceutical and medical device companies, with $2,294 received in 2024. These payments were reported across 876 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($13,796).
As a Medicare-enrolled provider, Page has provided services to 3,447 Medicare beneficiaries, totaling 6,299 services with total Medicare billing of $307,739. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Evansville, IN
- Active Since 05/31/2005
- Last Updated 01/08/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1598768848
Products in Payments
- VRAYLAR (Drug) $1,203
- UBRELVY (Drug) $815.85
- FARXIGA (Drug) $613.87
- Ozempic (Drug) $610.35
- JARDIANCE (Drug) $545.91
- BREZTRI (Drug) $506.69
- QULIPTA (Drug) $499.81
- CHANTIX (Drug) $370.87
- LYRICA (Drug) $290.84
- TRELEGY ELLIPTA (Drug) $272.30
- XIFAXAN (Drug) $268.58
- SHINGRIX (Biological) $267.43
- Auvelity (Drug) $252.76
- HETLIOZ (Drug) $242.66
- VOQUEZNA (Drug) $235.35
- AREXVY (Drug) $229.96
- TRINTELLIX (Drug) $226.93
- Aimovig (Biological) $215.56
- NURTEC ODT (Drug) $210.54
- VYVANSE (Drug) $195.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Evansville
David Schultz, M.d, M.D
Family Medicine — Payments: $756,324
Family Medicine $756,324
J Sartore, Md, MD
Family Medicine — Payments: $425,777
Family Medicine $425,777
Dr. Anthony Inzerello, M.d, M.D
Family Medicine — Payments: $315,157
Family Medicine $315,157
Carol Goodman, Md, MD
Family Medicine — Payments: $125,655
Family Medicine $125,655
Randall Oliver, M.d, M.D
Family Medicine — Payments: $75,540
Family Medicine $75,540
David Brougher, M.d, M.D
Family Medicine — Payments: $62,934
Family Medicine $62,934